Emotional disorders in patients with motor neuron disease in the Republic of Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2021.73.03
Abstract
The article describes a study of patients with motor neuron disease (MND) and their families using the Hospital Anxiety and Depression Scale (HADS). The frequency and severity of anxiety and depression in patients with MND and their family members were studied.
About the Authors
T. K. Davydova
Center for Neurodegenerative Diseases;
YSC KMP
Russian Federation
Russian Federation
Davydova Tatyana Kimovna, MD, PhD, Leading Researcher, Head;
Head of the Laboratory of Neurodegenerative Diseases
Yakutsk
S. S. Shadrina
North-Eastern Federal University
Russian Federation
Russian Federation
Shadrina Svetlana Semyonovna, Senior Researcher, Research Laboratory of Cell Technologies and Regenerative Medicine
Yakutsk
N. A. Schneider
Federal State Budgetary Institution National Medical Research Center for Psychiatry and Neurology named after V.M. Bekhterev, Ministry of Health of Russia;
Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky
Russian Federation
Russian Federation
Schneider Natalya Alekseevna, MD, DSc, Professor, Leading Researcher Center for Personalized Psychiatry and Neurology
St. Petersburg;
660022, Krasnoyarsk
P. S. Goncharova
FSBI National Medical Research Center for Psychiatry and Neurology named after I.I. V.M. Bekhterev, Ministry of Health of Russia
Russian Federation
Russian Federation
Goncharova Polina Sergeevna, neurologist-resident of the Center for Personalized Psychiatry and Neurology
St. Petersburg
R. F. Nasyrova
Center for Personalized Psychiatry and Neurology of the FSBI ‘National Medical Research Center for Psychiatry and Neurology named after V.I. V.M. Bekhterev’ Ministry of Health of Russia
Russian Federation
Russian Federation
Nasyrova Regina F., MD, PhD, Chief Researcher, Head
St. Petersburg
References
1. Yakhno N.N. ALS syndrome - dementia of the frontal type / N.N. Yakhno, M.S. Golovkova, I.S. Pereobpazhenskaya // Neurological journal. - 2002; 4: 12-18.
2. Brooks BR, MillerRG, SwasM [et al]. El- Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.Amyotroph. Lateral scler. Other Motor Neuron Disord. - 2000; Vol. 1 (5): 293-299.
3. Białkowska J., Mroczkowska D., Huflejt M.E. [et al] Complex treatment of amyotrophiclateral sclerosis patient. Acta Clin Croat. - 2019 Dec; 58(4): 757–766.doi: 10.20471/acc.2019.58.04.24
4. Benbrika S., Desgranges B., Eustache F. [et al.] Cognitive, Emotional and Psychological Manifestations in Amyotrophic Lateral Sclerosis at Baseline and Overtime: A Review. Front Neurosci. 2019; 13: 951.Published online 2019 Sep 10. doi: 10.3389/fnins.2019.00951
5. Cheng HWB,Chan OM, Chan CHR [et al]. End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease.Am J. Hosp. Palliat Care. - 2018; Jun. 35 (6): 847-851. DOI: 10.1177 / 1049909117735832. Epub 2017 Oct 15.
6. Carvalho T.L., Sanguinette de Almeida L.M., Araujo Lorega K.M.[et al] Depression and anxiety in individuals with amyotrophic lateral sclerosis: a systematic review Trends in Psychiatry and Psychotherapy January March 2016;38(1):1-5. doi: 10.1590/2237-6089-2015-0030.
7. Chen D., Guo X., Zheng Z. [et al.] Depression and anxiety in amyotrophic lateral sclerosis: correlations between the distress of patients and caregivers.Muscle Nerve. 2015 Mar;51(3):353-7. doi: 10.1002/mus.24325. Epub 2015 Jan 6
8. Godoy L.,Prado R., Santos Bicalho I.C. [et al.]. Depression and anxiety in a case series of amyotrophic lateral sclerosis: frequency and association with clinical features. Einstein (Sao Paulo). 2017;15(1):58-60. doi: 10.1590/S1679-45082017AO3870.
9. Hirano A, Kurland LT, Krooth RS. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain. 1961a; Vol. 84: 642-661.
10. Leighton DJ,Newton J, Stephenson LJ [et al.].Changing epidemiology of motor neurone disease in Scotland. J.Neurol. 2019; Apr.266(4): 817-825. DOI: 10.1007/s00415-019-09190-7. Epub.2019 Feb. 25, CARE-MND Consortium.
11. Lee Y-J, Lee G-W,Seo W-S [et al]. Neurofeedback Treatment on Depressive Symptoms and Functional Recovery in Treatment-Resistant Patients with Major Depressive Disorder: an Open-Label Pilot Study.J Korean Med Sci. 2019 Nov 4; 34(42): e287. Published online 2019 Oct 24. doi: 10.3346/jkms.2019.34.e287
12. Müller HP, GorgesM, Del Tredici K. The same cortico-efferent tract involvement in progressive bulbar palsy and in 'classical' ALS: A tract of interest-based MRI study. Neuroimage Clin. 2019;24:101979. DOI: 10.1016/j.nicl.2019.101979. Epub 2019 Aug 9.
13. Motataianu A., Andone S., Radu C. [et al.]. Predictors of Depression in Caucasian Patients with Amyotrophic Lateral Sclerosis in Romania. Brain Sci. 2020 Aug; 10(8): 470.Published online 2020 Jul 22. doi: 10.3390/brainsci10080470
14. Norris FN, Shepherd R, Denys E [et al.].Onset, natural history and outcome in idiopathic adult motor neuron disease. J.Neurol.Sci. 1993; 118:48-55.
15. Roos E, Mariosa D, Ingre C, Lundholm C, Wirdefeldt K, Roos PM. [et al.]. Depression in amyotrophic lateral sclerosis. Neurology. 2016; 86(24):2271–7. 10.1212/WNL.0000000000002671
16. Saberi S., Stauffer J.E., Schulte D.J.[et al]. Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurol Clin. 2015 Nov;33(4):855-76. doi: 10.1016/j.ncl.2015.07.012.
17. WijesekeraLC,Leigh PN. Amyotrophic lateral sclerosis. Orphanet J.Rare Dis. 2009; Feb. 3, 4:3. DOI: 10.1186/1750-1172-4-3.
Review
For citations:
Davydova T.K., Shadrina S.S., Schneider N.A., Goncharova P.S., Nasyrova R.F. Emotional disorders in patients with motor neuron disease in the Republic of Sakha (Yakutia). Yakut Medical Journal. 2021;(1):12-15. https://doi.org/10.25789/YMJ.2021.73.03
Views:
3
Email this article 